Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Nov-Dec, 2009 | Pubmed ID: 20586984